Louisville, United States
Medivance®, founded in 1998, has established itself as a market leader in Targeted Temperature Management™, primarily within the Biotechnology, Health Care, and Manufacturing industries.
The company's flagship product, the Arctic Sun, delivers non-invasive, precision Temperature Management Solutions that cater to both normothermia and hypothermia protocols. The device is prevalent in top hospitals globally, known for its ability to quickly and accurately manage patient temperatures.
Medivance® attracted notable attention in the investor community, securing a substantial $8.07M Venture Round investment in June 2009, which helped solidify their position in the market.
Since its acquisition by C. R. Bard® in 2011, the company has continued to contribute to advancements in patient care with its innovative solutions.
Headquartered in the United States, Medivance® remains an influential player in the field, embodying its slogan: "Optimizing Patient Care with Precision Temperature Management Solutions."
